4//SEC Filing
Elsbree David B 4
Accession 0000899243-22-024422
CIK 0001492674other
Filed
Jun 27, 8:00 PM ET
Accepted
Jun 28, 5:25 PM ET
Size
8.0 KB
Accession
0000899243-22-024422
Insider Transaction Report
Form 4
Elsbree David B
Director
Transactions
- Exercise/Conversion
Common Stock
2022-06-25+73,224→ 276,205 total - Exercise/Conversion
Restricted Stock Units
2022-06-25−73,224→ 0 total→ Common Stock (73,224 underlying)
Holdings
- 10,000(indirect: By Spouse)
Common Stock
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The reporting person disclaims ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
- [F3]On June 25, 2021, the reporting person was granted 73,224 restricted stock units that vested on the earlier of (i) June 25, 2022, and (ii) the date of the next annual meeting of stockholders.
Documents
Issuer
T2 Biosystems, Inc.
CIK 0001492674
Entity typeother
Related Parties
1- filerCIK 0001292650
Filing Metadata
- Form type
- 4
- Filed
- Jun 27, 8:00 PM ET
- Accepted
- Jun 28, 5:25 PM ET
- Size
- 8.0 KB